1

What’s In? What’s Out? The Popularity Contest in Psychiatric Drug Use

“Popularity is the easiest thing in the world to gain and it is the hardest thing to hold.”  That’s what Will Rogers famously thought–but he had obviously never met Xanax. Sometimes looking at the trajectories of various medications for mental… Continue Reading

1

Play It Again, Sam: Trying–and Failing–To Reproduce Scientific Results

With the release of Zyprexa, a second-generation antipsychotic, Eli Lilly was certain it had hit pay dirt. The second-generation antipsychotics, known as the atypical antipsychotics, or atypicals, had an improved side effect profile over the older antipsychotics, and the original… Continue Reading